ABOUT

QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market.  The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by:

​

• Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging

• Providing quantitative DNA integrity information, on a cell-by-cell basis

• Automatically sorting a semen sample according to objective consensus criteria

QART intends to commercially launch its system - a workstation and disposable cartridges - in year 2020, and commence marketing to fertility clinics, aiming to significantly improve pregnancy rates in ICSI procedures.

TEAM

Alon Shalev, MSc

CEO, Co-Founder

Entrepreneur, inventor and executive in the Med-Tech domain. Was co-founder and COO in BrainsGate, CEO in Nicast, co-founder and CEO in Endospan. Received his BSc and MSc (Summa Cum Laude) in Electrical Engineering from the Tel Aviv University

Prof. Natan T. Shaked, PhD

Chief Scientist, Co-Founder

Associate Professor in the Department of Biomedical Engineering at Tel Aviv University. Was a Visiting Assistant Professor in the Dept. of Biomedical Engineering at Duke University, Durham, NC, USA. Received his BSc, MSc (Summa Cum Laude), and PhD degrees in Electrical and Computer Engineering

Dr. Mattan Levi, PhD 

Director Translational Research

Manager of Andrology medical laboratory, Herzliya Medical Center, and prior to that, at the Meir Medical Center. Managed the of Oncology Research Laboratory, headed by Prof. Irit Ben Aharon, Rabin Medical Center and Technion Faculty of Medicine, Israel. Guest scientist in the laboratory of Prof. Natan Shaked at the Department of
BioMed. Eng. at Tel Aviv University.

Shimon Oz, MBA

Chief Financial Officer

M.B.A.  in Economics and Business Admin. & Masters Degree in Economics and Business Administration (with honors), Department of Economics, Hebrew University, Jerusalem. Served as an independent adviser acting as executive director and/or CFO, investment banker, and economic consultant for clients including Scitex Corp, Forum Film, Elan Jaglom Group, Mig Group, “Infinity VC Group and  Dekora Group, and others.

​

SCIENTIFIC PANEL

Prof Haim Breitbart, PhD

Professor Emeritus. President of Zefat Academic College (founded by Bar Ilan University). Former Dean of the Faculty of Life Sciences, Bar-Ilan University. Vice Dean of the Azrieli Faculty of Medicine of Bar-Ilan University

Prof Arie Raziel, MD

Head of IVF unit and male fertility center in Wolfson Medical Center. 25 years of experience in female and male fertility. Professor in Tel Aviv University School of Medicine

Dr Ilan Canderon, MD

Deputy Director of Bnai Zion Medical Center, Haifa; Director of the Assisted Reproductive Technology Unit. Received his MD from the Hebrew University of Jerusalem, Hadassah School of Medicine. He is board-certified in obstetrics and gynecology by the Israel Medical Council

Dr. Susan Alpert, MD, PhD

Dr. Alpert held the positions of senior vice president and chief regulatory officer at Medtronic until 2012 and a similar role at C.R. Bard. Before Medtronic, she held a number of positions with the FDA including as Director of the FDA’s Office of Device Evaluation. Dr. Alpert holds MD and Ph.D. in infectious diseases from the NYC School of Medicine.

Eliezer Girsh, PhD

Clinical embryologist and andrologist. Sperm lab and bank manager in Barzilay Medical Center. Dr. Girsch is a senior biologist and embryologist with years of experience in working with sperm and ova.